Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06213090 · ClinicalTrials.gov registry record
Patterns of Neurodevelopmental Disorders
A clinical trial of Autism Spectrum Disorder and Epilepsy, sponsored by Richard Frye.
- Recruiting
- Registry status
- 1,000
- Enrollment target
- 1
- Study location
NCT06213090 is a study of Autism Spectrum Disorder and Epilepsy that is actively recruiting participants, run by Richard Frye. The registered enrollment target is 1,000 participants, above the 131-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (663% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06213090, a study of Autism Spectrum Disorder and Epilepsy, is actively recruiting participants, sponsored by Richard Frye.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to systematically evaluate the results of medical investigations to identify symptom and biological patterns and common etiologies of neurodevelopmental disorders.
Conditions Studied
Study Locations (1)
Arizona
- Rossignol Medical Center - Phoenix
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2024-02-01 |
| Est. Completion | 2030-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06213090
The ClinicalTrials.gov registry entry for NCT06213090 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 131-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (663% higher). The listed sponsor is Richard Frye, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 8 conditions, with Autism Spectrum Disorder appearing as the primary indexed condition, and to 0 interventions.
NCT06213090 reports 1 study location spanning 1 distinct geographic area - top geographies include Arizona.
Frequently Asked Questions
What is clinical trial NCT06213090 about?
NCT06213090 is a clinical study titled "Patterns of Neurodevelopmental Disorders". The purpose of this study is to systematically evaluate the results of medical investigations to identify symptom and biological patterns and common etiologies of neurodevelopmental disorders.
What is the current status of trial NCT06213090?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2024-02-01. Estimated completion is 2030-12-31.
What conditions does trial NCT06213090 study?
This clinical trial studies the following conditions: Autism Spectrum Disorder, Epilepsy, Down Syndrome, Neurodevelopmental Disorders, Mitochondrial Encephalomyopathies.
Who is sponsoring clinical trial NCT06213090?
This trial is sponsored by Richard Frye, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06213090 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Autism Spectrum Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effect of an 8-Week Pickleball Program for Adults With Autism: A Feasibility Trial With a Delayed-Control Design
RECRUITING · Early Phase 1
-
Cannabidiol (CBD) in Adults With ASD
RECRUITING · Phase 1
-
COMPASS Across Settings (CAST) for Improving Transition Outcomes for Students With ASD
RECRUITING · NA
-
Pimavanserin for Rigid-compulsive Symptoms in Autism Spectrum Disorder
RECRUITING · Phase 2
-
Emergent Multi-Class Imitation Training
RECRUITING · NA
-
Physical Activity and Community EmPOWERment Project
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.